Medicenna Therapeutics, Inc.
MDNAF · Toronto, Ontario, Canada
Works in Dermatology · GI & liver · Infectious disease · Metabolic & endocrine · Neurology · Oncology · Renal & urogenital · Respiratory · Women's health
Medicenna Therapeutics, Inc. is a clinical trial sponsor based in Toronto, Ontario, Canada, listed as MDNAF. It has 1 active clinical trial with 160 planned participants, across 9 therapeutic areas. Since 2021 it has completed 1 trial and stopped 0 early.
Trial track record · since 2021
Financials · MDNAF
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Medicenna Therapeutics, Inc
Medicenna Therapeutics, Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 160 planned participants, in Dermatology, GI & liver, Infectious disease, Metabolic & endocrine and other areas. Since 2021 it has completed 1 trial and stopped 0 early.
Medicenna Therapeutics, Inc is based in Toronto, Ontario, Canada and is listed as MDNAF. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Medicenna Therapeutics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-30.
Approve Suite is not affiliated with Medicenna Therapeutics, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.